China Dips Its Toes in Disruptive IVD Tech

The number of Chinese IVD companies exhibiting at the 2015 American Association for Clinical Chemistry Annual Meeting (AACC) & Clinical Lab Expo (CLE) was slightly down from last year, but the breadth of diagnostic products and innovations from China appears to be on the up. Hrishi Poola and Jon Chen discuss the moves China is making to become a generator of disruptive technologies and reports on the new products and the players emerging from this market

This year’s AACC & CLE, which took place July 27-30 in Atlanta, Georgia, featured 92 China-based companies, slightly down from last year's record turnout of 98 exhibitors. Over the years, China-based suppliers have diversified far beyond the early days of semi-automated systems, ELISA/MTP offerings, three-part differential hematology, and chemistry reagents. In Atlanta, China-based players showcased a range of clinical chemistry laboratory systems (CCLS), chemiluminescence immunoassay (CLIA), integrated chemistry/immunoassay work cells, and products related to hematology, coagulation, molecular testing, rapid testing, point-of-care (POC), flow cytometry, and urinalysis.

Despite offering expanded product portfolios and increased technology sophistication, China-based vendors still lag behind multinational companies when it comes to quality, service, distribution channels, commercial experience and internal R&D/discovery programs....

More from Asia

More from Geography